Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-04

Clinical Trial Update: Ketamine Low dOse Evaluation on Morphine Consumption in Traumatic Patient [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating whether low-dose ketamine reduces morphine consumption in patients with traumatic injury has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine (ketamine)

Snippet

Sponsor: Assistance Publique Hopitaux De Marseille | Conditions: Traumatic Injury | Phase 3 | Status: COMPLETED